Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacture — a key step in bringing new drugs to market. Once a promising drug has been identified in the lab, pharma firms need to be able to produce much larger amounts of the […]
YC-backed ReactWise is applying AI to speed up drug manufacturing Read More »
Last week, at the Abundance Summit in Los Angeles, billionaire entrepreneur Travis Kalanick gave attendees a rare glimpse into his vision for the future of his newest company, CloudKitchens. While today the eight-year-old L.A.-based outfit is known for a growing real estate portfolio that it uses to it host – and set up – restaurants
Travis Kalanick wants to do a lot more than develop more ghost kitchens Read More »
In the same way that genome sequencing determines the genetic makeup of an organism, Bryan Johnson — the investor and founder behind the Don’t Die movement – wants to start “foodome” sequencing. “We’re going to sequence the U.S. ‘foodome,’ which means test 20% of foods that constitute 80% of the American diet based on stuff
Anti-aging zealot Bryan Johnson wants to start ‘foodome sequencing’ Read More »
VC funding into AI tools for healthcare was projected to hit $11 billion last year — a headline figure that speaks to the widespread conviction that artificial intelligence will prove transformative in a critical sector. Many startups applying AI in healthcare are seeking to drive efficiencies by automating some of the administration that orbits and
Hinge Health, a 10-year-old company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, filed to go public. Although Hinge has not yet announced how many shares, nor priced them, the IPO specialists at Renaissance Capital estimate the company hopes to raise up to $500 million in its offering. Hinge’s revenue in 2024
Virtual physical therapists Hinge Health files for IPO, estimated to raise $500M Read More »
Medical devices, wearables — we are all familiar with them. But are they linked in any way to the healthcare system and the databases that are supposed to keep us healthy? The answer in most cases is no, they are not. Vital, which is rebranding to “Junction”, provides a single API to integrate wearables and
Junction, an API to link health wearables with labs, raises $18M Read More »
Medical imaging is a broad term that encompasses several distinct technologies. After working on AI-powered tools to enhance X-rays and mammographies, French startup Gleamer now aims to tackle magnetic resonance imaging (MRI). Instead of starting from scratch, Gleamer has acquired two startups that have already been working on AI-powered MRI analysis: Pixyl and Caerus Medical.
Radiology AI software provider Gleamer expands into MRI with two small acquisitions Read More »
The CEO of Colossal, a startup that aims to use genetic editing techniques to bring back extinct species, including the wooly mammoth, assured audiences at SXSW that the company has no plans to create a real-life Jurassic Park — lest there was any doubt. “Modern conservation isn’t working […] and we’re gonna need a ‘de-extinction’
Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: if someone does have cancer, is an aggressive treatment like chemotherapy
Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that. Read More »
Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: If someone does have cancer, is an aggressive treatment like chemotherapy
Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment Read More »
